Impaired FEF25-75 may predict high exhaled nitric oxide values in children with allergic rhinitis and/or asthma

Journal of Biological Regulators and Homeostatic Agents

Volumn 26, Issue 1 SUPPL, 2012, Pages

  Ciprandi, Giorgio ^a   Tosca, M A ^b   Cirillo, I ^c   Lionetti, E ^d   Leonardi, S ^d   Miraglia Del Giudice, M ^e   La Rosa, M ^d   Salpietro, A ^f   Capasso, M ^g   Marseglia, G L ^h  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c Navy Medical Service   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

^e SECOND UNIVERSITY OF NAPLES   (Italy)

^f UNIVERSITY OF MESSINA   (Italy)

^g Ospedale Civile Ave Gratia Plena   (Italy)

^h UNIVERSITY OF PAVIA   (Italy)

Author keywords

Allergic rhinitis; Asthma; Children; Nitric oride

Indexed keywords

NITRIC OXIDE;

ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; BRONCHUS HYPERREACTIVITY; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EXPIRED AIR; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; RESPIRATORY FUNCTION; SCHOOL CHILD; SENSITIZATION; ADOLESCENT; ASTHMA; BREATH ANALYSIS; MAXIMAL MID EXPIRATORY FLOW; METABOLISM; PATHOPHYSIOLOGY; PERENNIAL RHINITIS; PHYSIOLOGY; STATISTICAL MODEL;

ADOLESCENT; ASTHMA; BREATH TESTS; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MAXIMAL MIDEXPIRATORY FLOW RATE; NITRIC OXIDE; RHINITIS, ALLERGIC, PERENNIAL;

EID: 84873893968     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Global Initiative for Asthma. Pocket Guide for Asthma Management and Prevention. National Hearth, Lung and Blood Institute, National Institute of Health, Bethesda, MD, 1997, NIH Publication no. 96-3659B.
2. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy 2008; 63(Suppl. 86):8-160
3. Bukstein D, Kraft M, Liu AH. Asthma end points and outcomes what have we learned? J Allergy Clin Immunol 2006; 118:S1-S15 (Pubitemid 44508697)
4. American Thoracic Society, European Respiratory Society, ATS/ERS recommendations for standardized procedures for the online and offiine measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide 2005. Am J Respir Crit Care Med 2005; 171:912-30
5. Lim KG, Mottram C. The use of fraction of exhaled nitric oxide in pulmonary practice. Chest 2008;133:1232-42 (Pubitemid 351685531)
6. Pendharkar S, Mehta S. The clinical significance of exhaled nitric oxide in asthma. Can Respir J 2008; 15:99-106 (Pubitemid 351676398)
7. Roadway GW, Chol JY, Hoffman LA, Sethi JM. Exhaled nitric oxide in the diagnosis and management of asthma: clinical implications. Chron Respir Dis 2009; 6:19-29
8. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005; 26:948-68. (Pubitemid 41632054)
9. Miller MR, Hankinson J, Brusasco V, Burgos R, Casaburi R, Coates R, et al. Standardisation of spirometry. Eur Respir J. 2005; 26:319-38. (Pubitemid 41079078)
10. Ciprandi G, Cirillo I, Vizzaccaro A, Tosca MA, Passalacqua G, Pallestrini E, et al. Seasonal and perennial allergic rhinitis: is this classification adherent to real life? A population based study. Allergy. 2005; 60:882-7. (Pubitemid 40813809)
11. Simon MR, Chinchilli VM, Phillips BR, Sorkness CA, Lemanske RF, Szefler SJ, et al. Forced expiratory flow between 25% and 75% of vital capacity and FEV1/forced vital capacity ration in relation to clinical and physiological parameters in asthmatic children with normal FEV1 values. J Allergy Clin Immunol 2010; 126:527-34
12. 25-75 might be a predictive factor. Allergy Asthma Proc 2011; 32:4-8
13. Ciprandi G, Tosca MA, Capasso M. Exhaled nitric oxide in children with allergic rhinitis and/or asthma: a relationship with bronchial hyperreactivity. J Asthma 2010; 47:1142-7
14. Pederson PA, Weeke ER Asthma and allergic rhinitis in the same patients. Allergy 1983; 38:25-9 (Pubitemid 13177810)
15. Bugiani M, Carosso A, Migliore E, Piccioni P, Corsico A, Olivieri M, et al. Allergic rhinitis and asthma comorbidity in a survey of young adults in Italy. Allergy 2005; 60:165-70 (Pubitemid 40187469)
16. Asher I. ISAAC International Study of Asthma and Allergies in Childhood. Pediatr Pulmonol. 2007; 42(1):100-22
17. Dreborg S (Ed.). EAACI Subcommittee on Skin Tests. Skin tests used in type I allergy testing. Position Paper. Allergy 1989; 44 (Suppl.10):22-31
18. Swinscow TDV. Statistics at square one. Ninth Edition, Revised by Campbell MJ, University of Southampton, BMJ publishing Group, 1997
19. Ohkura N, Fujimura M, Tokuda A, Furusho S, Abo M, Katayama N. Evaluation of airway hyperresponsiveness and exhaled nitric oxide as risk factors for airway remodeling in patients with stable asthma. Allergy Asthma Proc. 2009; 30:419-23.
20. Ciprandi G, Cirillo I. The lower airway pathology of rhinitis. J Allergy Clin Immunol 2006; 118:1105-9. (Pubitemid 44666971)
21. Amorim MM, Araruna A, Caetano LB, Cruz AC, Santoro LL, Fernandes LG. Nasal eosinophilia: an indicator of eosinophilic inflammation in asthma. Clin Exp Allergy 2010; 40:867-74
22. 25-75 as an early marker of bronchial impairment in patients with seasonal allergic rhinitis. Am J Rhinol. 2006; 20:641-7.
23. 25-75 as predictor of bronchial hyperreactivity in allergic patients. Ann Allergy Asthma Immunol. 2006; 96:692-700
24. 25-75 may be a marker of bronchial impairment in allergic rhinitis. J Allergy Clin Immunol 2011; 127:549-51
25. 25-75 may be a marker of bronchial impairment. Ann Allergy Asthma Immunol 2011 (in press)
26. 25-75 might be a predictive factor for bronchial hyperreactivity in children with allergic rhinitis, asthma, or both. Allergy Asthma Proc 2011 (in press)
27. 25-75 may predict high exhaled nitric oxide values in children with allergic rhinitis and/or asthma. The Child 2012;1:1.